dose-length product
Patients who underwent 4-phase scanning (pre- contrast + arterial + portal venous + delayed phase) had an average dose-length product (DLP) of 1680.99 ± 346.89 mGy.cm (ranging from 576.54 mGy.cm to 2374.16 mGy.cm).
Patients who underwent 4-phase scanning ( pre- contrast + arterial + portal venous + delayed phase ) had an average dose-length product ( DLP ) of 1680 .99 ± 346 .89 mGy .cm ( ranging from 576 .54 mGy .cm to 2374 .16 mGy .cm ) .